Search results
Results from the WOW.Com Content Network
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. [2] Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion .
Subsequently, there was a tendency to intensify treatment in head and neck cancer, and many centres adopted a dose of 66 Gy, at least for those patients with adverse tumour features. [120] The effectiveness of PORT in HPV+OPC receives some support from a cohort study (Level 2b), although the number of patients was low, and the number of events ...
Cetuximab (trade name: Erbitux ) is a recombinant chimeric monoclonal antibody designed to treat metastatic colorectal cancer and head and neck cancer. [14] In numerous cancers, the epidermal growth factor receptor (EGFR) is often inappropriately activated and overexpressed in cancer cells, leading to uncontrolled cell growth. [15]
The trial consists of 2 parts: Dose escalation, and expansion. The trial is structured similar to previous trials with MM-151 but slightly more selective with patients diagnosed with Colorectal Cancer, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck only. The trial is expected to be completed in December 2016. [6]
Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say that individuals experiencing accelerated aging may benefit from earlier screenings.
Abigail Burroughs was a college student diagnosed with head and neck cancer. During the later phases of her treatment, Abigail's father, Frank Burroughs, formed an organization, the Abigail Alliance for Better Access to Developmental Drugs and sued the FDA for access to Erbitux.
Patients are typically offered testing if they have either a personal or family history of cancer that meets certain criteria, Zakalik adds. Those criteria have broadened over the last few years ...
Among these studies, many have linked red meat consumption to the development of several chronic conditions, including colorectal and other types of cancer, type 2 diabetes, cardiovascular ...